J Korean Med Sci.
2014 Aug;29(8):1182-1182. 10.3346/jkms.2014.29.8.1182.
Erratum: Addition of Author's Affiliated Institute and Correction of the Author's Name. Corrected: Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
- Affiliations
-
- 1EuBiologics Co., Ltd., Chuncheon, Korea.
- 2Department of Pharmacology and Clinical Trials Center, Chungnam National University, College of Medicine and Hospital, Daejeon, Korea.
- 3Clinical Immunology Section, International Vaccine Institute (IVI), Seoul, Korea.
- 4Department of Biotechnology, Korea University, Seoul, Korea.
- KMID: 2129619
- DOI: http://doi.org/10.3346/jkms.2014.29.8.1182
Abstract
- We found errors in our published article.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
- Erratum: Author's Name Correction. Dapsone Hypersensitivity Syndrome with EBV Reactivation
- Erratum: Author Correction
- Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
- Erratum to: A real time surface electromyography signal driven prosthetic hand model using PID controlled DC motor
